(Press-News.org) Researchers at the University of Chicago Medicine Comprehensive Cancer Center established “proof-of-concept” for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.
These findings, which were published online September 18, 2023, in Clinical Cancer Research, warrant further investigation in human clinical trials, the researchers concluded.
Strategies to overcome resistance
“Prostate cancer in the metastatic setting is a hormonally driven disease, and thus is typically treated with androgen deprivation therapy (ADT) to lower testosterone levels,” said Akash Patnaik, MD, PhD, MMSc, an accomplished physician-scientist and internationally-recognized expert in prostate cancer research and treatment, who is the senior author of the publication. “Although this form of treatment has been shown to have significant anti-cancer responses in patients, the majority will become resistant to hormonal therapy, or castrate-resistant.”
Advanced prostate cancers that don’t respond to standard hormone-based therapy, chemotherapy and immunotherapy leave patients with very few options. The development of treatments for these aggressive cancers known as metastatic castrate-resistant prostate cancer (mCRPC) represents an area of critical unmet need.
Patnaik’s lab develops targeted therapeutic strategies to improve the responsiveness of prostate cancer to immunotherapy. They discovered that the immune system can often promote the growth of cancer — instead of suppressing it — through recruitment of abnormal tumor-associated macrophages that express PD-1 (a checkpoint molecule which turns off an anti-cancer immune response) into the tumor microenvironment.
In a study published in March 2023, Patnaik and colleagues found that co-targeting the PI3K and PD-1 pathway enhanced the antitumor effects of ADT in PTEN-deficient prostate cancer, which is an aggressive form of advanced prostate cancer that results from the loss of a particular gene that keeps cell growth in check.
However, they observed that their strategy significantly enhanced the response rate for 60% of the mice, but 40% remained resistant to the therapy. The team conducted follow-up studies and found that activation of Wnt/β-catenin pathway restored lactate production in the treatment-resistant cancers, which they discovered drives the tumor-promoting properties of macrophages.
A paradigm shift
During the course of their studies, they discovered that lactate can crosstalk with macrophages and modify them via process called histone lactylation. This change makes the macrophages immunosuppressive, so they promote the growth of the cancer rather than suppress it.
In the current study, they discovered that resistance to PI3K inhibitors is mediated by Wnt/β-catenin and MEK signaling pathways. They co-targeted PI3Ki/MEK signaling pathways, which resulted in an 80% response rate. They observed that the 20% non-responders had a similar feedback activation of Wnt/β-catenin signaling.
They then tested a therapy regimen that consisted of three drugs targeting the PI3K, MEK, and Wnt/β-catenin signaling pathways. This brought the response rate to 100%.
“We were concerned about toxicity with continuous drug administration over the long-term, as is often the case with drug combinations in patients, so we did survival studies in mice with intermittent dosing of the same three drugs,” Patnaik said.
The researchers were excited to see that the intermittent dosing schedule resulted in complete tumor control and significantly prolonged survival without long-term toxicity associated with continuous drug administration.
Patnaik says collectively, their findings provide “proof-of-concept” that targeting lactate as a macrophage phagocytic checkpoint controls the growth of PTEN/p53-deficient prostate cancer and warrant further investigation in clinical trials.
Moreover, the idea that the drugs can perturb signaling pathways in the cancer cells that affect the metabolic output of the cancer cell and cross-talk with tumor-promoting macrophages unveils new therapeutic opportunities that have not been previously pursued.
“We don't necessarily need to use targeted therapies to kill cancer cells but instead harness their ability to flip the switch in macrophages,” Patnaik said. “Now the macrophages can eat the cancer cells and control the cancer.”
Patnaik said the next step in this research would be testing this concept in the clinic. “We would develop a phase 1 clinical trial looking at testing an intermittent dosing approach to see if we can achieve a similar immune-activating and anti-tumor response as we've seen in our mouse model.”
The study, “Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis,” was supported by funding from the Prostate Cancer Foundation Izzy Englander Challenge Award and the National Cancer Institute.
Additional authors include Kiranj Chaudagar, Hanna M. Hieromnimon, Anne Kelley, Brian Labadie, Jordan Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela Bynoe, Ani Solanki, Erica Markiewicz, Xiaobing Fan from Dr. Patnaik’s team at the University of Chicago and collaborator Massimo Loda from Weill Cornell Medicine.
Personalized combination treatment turns on an immunometabolic switch to effectively control an aggressive form of prostate cancer
ELSE PRESS RELEASES FROM THIS DATE:
Power meals: Child care-provided meals are associated with improved child and family health
Philadelphia, September 18, 2023 – Very young children who attend child care and receive onsite meals and snacks were more likely to be food secure and in good health, and less likely to be admitted after a hospital emergency department visit than children in child care whose meals and snacks were provided from home, according to a new study in the Journal of the Academy of Nutrition and Dietetics, published by Elsevier. These potential benefits could extend beyond the children themselves to their families, including through possible reductions in stress, and to society as a whole through potentially significant healthcare cost savings. Lead author Stephanie ...
DOE backs Rice study of how soils store carbon
HOUSTON – (Sept. 18, 2023) – Two Rice University scientists have received a 3-year grant from the Department of Energy (DOE) to investigate a form of carbon storage that is as little understood as it is ubiquitous: soil. Mark Torres, an assistant professor of Earth, environmental and planetary sciences, and Evan Ramos, a postdoctoral fellow in the Torres lab, will track how key minerals form in a watershed to build a fuller picture of the processes that allow soil to store carbon as organic matter. “Soil on Earth contains three times more carbon than the atmosphere,” Ramos said. “We ...
University of Colorado Anschutz Medical Campus receives $54 million from NIH
The National Institutes of Health has awarded $54 million over a seven-year period to the CCTSI at CU Anschutz. The grant from the National Center for Advancing Translational Sciences (NCATS) will fuel biomedical research and training across the state. This is the fourth consecutive time the NIH has funded the CCTSI since 2008 through its Clinical Translational Science Award (CTSA) program. “This powerful grant will allow the University of Colorado to conduct leading-edge research that can directly impact health and patient care, reduce health disparities across our state and remain poised to respond to public ...
UNIST and Pusan National University Yangsan Hospital collaborate on advanced 3D printing medical device technology
UNIST, in collaboration with Pusan National University Yangsan Hospital, has embarked on an exciting joint venture to research and develop advanced 3D printing medical device technology. The UNIST 3D Printing Convergence Technology Center recently signed a business agreement with the Medical Device Usability Test Center at Pusan National University Yangsan Hospital. This agreement outlines their collaborative efforts in various areas, including the research and development of 3D printing-based medical devices as well as support for the commercialization of domestically developed devices. Notably, Yangsan Pusan National University ...
The missing link to make easy protein sequencing possible?
There has been a real race among scientists to create a technology that enables easy protein sequencing. Professor of Chemical Biology Giovanni Maglia of the University of Groningen has now found the missing piece in the puzzle: a way to transport a protein through a nanopore, which allows sequencing of proteins in a simple, handheld device. DNA sequencing has been a revolution in how we understand life, and sequencing proteins is the next holy grail. Maglia explains: ‘DNA is mostly static. The processes in our cells are executed by proteins: they do the actual work. ...
Ochsner Health to integrate generative AI into patient messaging
This month, Ochsner Health is launching a pilot program that uses AI to draft simple messages to patients in the MyOchsner app portal. A small group of Ochsner clinicians will participate in testing a new Epic feature that drafts responses to routine patient requests, which will then be reviewed and edited by the clinicians. The feature is meant to speed up app response time to patients and allows doctors to spend more time with patients. “Ochsner has long been a leader in using digital tools to improve the patient experience,” said Ochsner ...
Using augmented reality to make Parkinson's disease physical therapy more accessible
An augmented-reality headset is an effective digital tool for improving posture and gait in people with Parkinson’s disease, according to a recent Cleveland Clinic trial. Findings were published in Neurorehabilitation and Neural Repair. Augmented reality, or AR, allows users to complete digital programs projected into the world around them. The “Dual-task augmented Reality Treatment” (DART) uses the Microsoft HoloLens2 to run patients through dual-task training (DTT), a series of tasks designed to engage the brain and body simultaneously. Activities ...
State grant allows for UC’s continued research on firefighter protective gear
A team of UC researchers across three colleges has been awarded an additional $1.5 million state grant to continue research on improving firefighter protective gear. In 2022, the Ohio Bureau of Workers’ Compensation (BWC) awarded a UC team an initial $1.2 million to provide proof of concept on the development of a firefighter jacket liner that brings a firefighter’s body temperature down through advanced cooling technology and protects the body from other external hazards. That grant, and the new $1.5 million grant to carry the proof of concept to commercialization, ...
Pediatric ED visits, hospitalizations for self-harm up during pandemic, especially in adolescent females; "Less is better" is the best message when talking to patients about alcohol
CMAJ headlines: Pediatric ED visits and hospitalizations for self-harm, suicidal thoughts increased in Canada during pandemic, especially in young adolescent females "Less is better" is the best message when talking to patients about alcohol Pediatric ED visits and hospitalizations for self-harm, suicidal thoughts increased in Canada during pandemic, especially in young adolescent females The COVID-19 pandemic had an outsized impact on the mental health of adolescents, especially young adolescent females, with a higher-than-expected number of emergency department (ED) visits and hospitalizations for self-harm and suicidal ideation, according to two new research ...
Study explores how healthcare workers share appreciation, promote positive workplace culture
Healthcare organizations, in reviewing care delivery opportunities and providing feedback to staff, often focus on what went wrong, but a new study suggests that reversing this perspective may help organizations improve their work culture by understanding what went right. A team of Mass General Brigham researchers analyzed peer-to-peer positive feedback, systematically collected when caring for a dying patient as part of a mandatory mortality review process. They found that standardized collection and sharing of positive feedback — what went right — is a feasible way to increase mutual ...